{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T20:00:40Z","timestamp":1759694440021},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s11920-008-0082-6","type":"journal-article","created":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T10:11:13Z","timestamp":1231323073000},"page":"520-524","source":"Crossref","is-referenced-by-count":7,"title":["Adjunctive use of modafinil in bipolar patients: just another stimulant or not?"],"prefix":"10.1007","volume":"10","author":[{"given":"Richard C.","family":"Shelton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,8]]},"reference":[{"key":"82_CR1","doi-asserted-by":"crossref","unstructured":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology 2000, 54:1166\u20131175.","DOI":"10.1212\/WNL.54.5.1166"},{"key":"82_CR2","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1164\/ajrccm.164.9.2103032","volume":"164","author":"A.I. Pack","year":"2001","unstructured":"Pack AI, Black JE, Schwartz JR, Matheson JK: Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001, 164:1675\u20131681.","journal-title":"Am J Respir Crit Care Med"},{"key":"82_CR3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa041292","volume":"353","author":"C.A. Czeisler","year":"2005","unstructured":"Czeisler CA, Walsh JK, Roth T, et al.: Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med 2005, 353:476\u2013486.","journal-title":"N Engl J Med"},{"key":"82_CR4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-2999(96)00182-3","volume":"306","author":"L. Ferraro","year":"1996","unstructured":"Ferraro L, Tanganelli S, O\u2019Connor WT, et al.: The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol 1996, 306:33\u201339.","journal-title":"Eur J Pharmacol"},{"key":"82_CR5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(03)00006-5","volume":"339","author":"T. Ishizuka","year":"2003","unstructured":"Ishizuka T, Sakamoto Y, Sakurai T, Yamatodani A: Modafinil increases histamine release in the anterior hypothalamus of rats. Neurosci Lett 2003, 339:143\u2013146.","journal-title":"Neurosci Lett"},{"key":"82_CR6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbr.2006.10.016","volume":"176","author":"E. Murillo-Rodr\u00edguez","year":"2007","unstructured":"Murillo-Rodr\u00edguez E, Haro R, Palomero-Rivero M, et al.: Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats. Behav Brain Res 2007, 176:353\u2013357.","journal-title":"Behav Brain Res"},{"key":"82_CR7","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1523\/JNEUROSCI.20-22-08620.2000","volume":"20","author":"T.E. Scammell","year":"2000","unstructured":"Scammell TE, Estabrooke IV, McCarthy MT, et al.: Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000, 20:8620\u20138628.","journal-title":"J Neurosci"},{"key":"82_CR8","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1523\/JNEUROSCI.21-05-01656.2001","volume":"21","author":"I.V. Estabrooke","year":"2001","unstructured":"Estabrooke IV, McCarthy MT, Ko E, et al.: Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001, 21:1656\u20131662.","journal-title":"J Neurosci"},{"key":"82_CR9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.brainres.2003.08.044","volume":"992","author":"E.M. Ko","year":"2003","unstructured":"Ko EM, Estabrooke IV, McCarthy M, Scammell TE: Wake-related activity of tuberomammillary neurons in rats. Brain Res 2003, 992:220\u2013226.","journal-title":"Brain Res"},{"key":"82_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(96)13212-2","volume":"220","author":"L. Ferraro","year":"1996","unstructured":"Ferraro L, Tanganelli S, O\u2019Connor WT, et al.: The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor. Neurosci Lett 1996, 220:5\u20138.","journal-title":"Neurosci Lett"},{"key":"82_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(02)00324-5","volume":"73","author":"L.L. Judd","year":"2003","unstructured":"Judd LL, Akiskal HS, Schettler PJ, et al.: The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord 2003, 73:19\u201332.","journal-title":"J Affect Disord"},{"key":"82_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4088\/JCP.v64n0111","volume":"64","author":"R.M. Hirschfeld","year":"2003","unstructured":"Hirschfeld RM, Calabrese JR, Weissman MM, et al.: Screening for bipolar disorder in the community. J Clin Psychiatry 2003, 64:53\u201359.","journal-title":"J Clin Psychiatry"},{"key":"82_CR13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","volume":"60","author":"M. Tohen","year":"2003","unstructured":"Tohen M, Vieta E, Calabrese J, et al.: Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003, 60:1079\u20131088.","journal-title":"Arch Gen Psychiatry"},{"key":"82_CR14","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","volume":"162","author":"J.R. Calabrese","year":"2005","unstructured":"Calabrese JR, Keck PE Jr, Macfadden W, et al.: A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005, 162:1351\u20131360.","journal-title":"Am J Psychiatry"},{"key":"82_CR15","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1176\/appi.ajp.158.6.906","volume":"158","author":"C.B. Nemeroff","year":"2001","unstructured":"Nemeroff CB, Evans DL, Gyulai L, et al.: Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001, 158:906\u2013912.","journal-title":"Am J Psychiatry"},{"key":"82_CR16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4088\/JCP.v63n0607","volume":"63","author":"E. Vieta","year":"2002","unstructured":"Vieta E, Martinez-Aran A, Goikolea JM, et al.: A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 2002, 63:508\u2013512.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl4","key":"82_CR17","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/S0924-977X(99)00024-3","volume":"9","author":"C.L. Bowden","year":"1999","unstructured":"Bowden CL, Mitchell P, Suppes T: Lamotrigine in the treatment of bipolar depression. Eur Neuropsychopharmacol 1999, 9(Suppl 4):S113\u2013S117.","journal-title":"Eur Neuropsychopharmacol"},{"key":"82_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2004.09.009","volume":"85","author":"L.L. Davis","year":"2005","unstructured":"Davis LL, Bartolucci A, Petty F: Divalproex in the treatment of bipolar depression: a placebo-controlled study. J Affect Disord 2005, 85:259\u2013266.","journal-title":"J Affect Disord"},{"key":"82_CR19","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","volume":"356","author":"G.S. Sachs","year":"2007","unstructured":"Sachs GS, Nierenberg AA, Calabrese JR, et al.: Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007, 356:1711\u20131722.","journal-title":"N Engl J Med"},{"key":"82_CR20","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1399-5618.2003.00065.x","volume":"5","author":"R.M. Post","year":"2003","unstructured":"Post RM, Leverich GS, Nolen WA, et al.: A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord 2003, 5:396\u2013406.","journal-title":"Bipolar Disord"},{"key":"82_CR21","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.4088\/JCP.v65n1218","volume":"65","author":"R.C. Shelton","year":"2004","unstructured":"Shelton RC, Stahl SM: Risperidone and paroxetine given singly and in combination for bipolar depression. J Clin Psychiatry 2004, 65:1715\u20131719.","journal-title":"J Clin Psychiatry"},{"key":"82_CR22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11920-006-0056-5","volume":"8","author":"R.M. Post","year":"2006","unstructured":"Post RM, Altshuler LL, Frye MA, et al.: New findings from the Bipolar Collaborative Network: clinical implications for therapeutics. Curr Psychiatry Rep 2006, 8:489\u2013497.","journal-title":"Curr Psychiatry Rep"},{"key":"82_CR23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1517\/14656566.8.1.13","volume":"8","author":"P.J. Goodnick","year":"2007","unstructured":"Goodnick PJ: Bipolar depression: a review of randomised clinical trials. Expert Opin Pharmacother 2007, 8:13\u201321.","journal-title":"Expert Opin Pharmacother"},{"key":"82_CR24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","volume":"60","author":"C.L. Bowden","year":"2003","unstructured":"Bowden CL, Calabrese JR, Sachs G, et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003, 60:392\u2013400.","journal-title":"Arch Gen Psychiatry"},{"key":"82_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","volume":"60","author":"J.R. Calabrese","year":"1999","unstructured":"Calabrese JR, Bowden CL, Sachs GS, et al.: A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999, 60:79\u201388.","journal-title":"J Clin Psychiatry"},{"key":"82_CR26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","volume":"64","author":"J.R. Calabrese","year":"2003","unstructured":"Calabrese JR, Bowden CL, Sachs G, et al.: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003, 64:1013\u20131024.","journal-title":"J Clin Psychiatry"},{"key":"82_CR27","first-page":"377","volume":"6","author":"T. Wehr","year":"1979","unstructured":"Wehr T, Goodwin FK: Tricyclics modulate frequency of mood cycles. Chronobiologia 1979, 6:377\u2013385.","journal-title":"Chronobiologia"},{"key":"82_CR28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archpsyc.1993.01820180097011","volume":"50","author":"T.A. Wehr","year":"1993","unstructured":"Wehr TA: Can antidepressants induce rapid cycling? Arch Gen Psychiatry 1993, 50:495\u2013496.","journal-title":"Arch Gen Psychiatry"},{"key":"82_CR29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4088\/JCP.v62n0807","volume":"62","author":"L. Altshuler","year":"2001","unstructured":"Altshuler L, Kiriakos L, Calcagno J, et al.: The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry 2001, 62:612\u2013616.","journal-title":"J Clin Psychiatry"},{"key":"82_CR30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/jcp.0b013e31802eb7ea","volume":"27","author":"I. Taneja","year":"2007","unstructured":"Taneja I, Haman K, Shelton RC, Robertson D: A randomized, double-blind, crossover trial of modafinil on mood. J Clin Psychopharmacol 2007, 27:76\u201379.","journal-title":"J Clin Psychopharmacol"},{"key":"82_CR31","first-page":"185","volume":"6","author":"H. Marin","year":"2005","unstructured":"Marin H, Menza MA: The management of fatigue in depressed patients. Essent Psychopharmacol 2005, 6:185\u2013192.","journal-title":"Essent Psychopharmacol"},{"key":"82_CR32","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4088\/JCP.v64n0911","volume":"64","author":"C. DeBattista","year":"2003","unstructured":"DeBattista C, Doghramji K, Menza MA, et al.: Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. J Clin Psychiatry 2003, 64:1057\u20131064.","journal-title":"J Clin Psychiatry"},{"key":"82_CR33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0924-9338(02)00646-6","volume":"17","author":"K.R. Kaufman","year":"2002","unstructured":"Kaufman KR, Menza MA, Fitzsimmons A: Modafinil monotherapy in depression. Eur Psychiatry 2002, 17:167\u2013169.","journal-title":"Eur Psychiatry"},{"key":"82_CR34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10401230701464858","volume":"19","author":"M. Fava","year":"2007","unstructured":"Fava M, Thase ME, DeBattista C, et al.: Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Ann Clin Psychiatry 2007, 19:153\u2013159.","journal-title":"Ann Clin Psychiatry"},{"key":"82_CR35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S1092852900010622","volume":"11","author":"M.E. Thase","year":"2006","unstructured":"Thase ME, Fava M, DeBattista C, et al.: Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. CNS Spectr 2006, 11:93\u2013102.","journal-title":"CNS Spectr"},{"key":"82_CR36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4088\/JCP.v67n0120","volume":"67","author":"J.M. Swanson","year":"2006","unstructured":"Swanson JM, Greenhill LL, Lopez FA, et al.: Modafinil film-coated tablets in children and adolescents with attention-deficit\/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry 2006, 67:137\u2013147.","journal-title":"J Clin Psychiatry"},{"key":"82_CR37","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1345\/aph.1D226","volume":"37","author":"P.P. Fernandes","year":"2003","unstructured":"Fernandes PP, Petty F: Modafinil for remitted bipolar depression with hypersomnia. Ann Pharmacother 2003, 37:1807\u20131809.","journal-title":"Ann Pharmacother"},{"key":"82_CR38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/01.jcp.0000185346.77966.a4","volume":"25","author":"S. Ranjan","year":"2005","unstructured":"Ranjan S, Chandra PS: Modafinil-induced irritability and aggression? A report of 2 bipolar patients. J Clin Psychopharmacol 2005, 25:628\u2013629.","journal-title":"J Clin Psychopharmacol"},{"key":"82_CR39","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4088\/JCP.v67n1122a","volume":"67","author":"J. Wolf","year":"2006","unstructured":"Wolf J, Fiedler U, Anghelescu I, Schwertfeger N: Manic switch in a patient with treatment-resistant bipolar depression treated with modafinil. J Clin Psychiatry 2006, 67:1817.","journal-title":"J Clin Psychiatry"},{"key":"82_CR40","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.pnpbp.2007.11.006","volume":"32","author":"K.N. Fountoulakis","year":"2008","unstructured":"Fountoulakis KN, Siamouli M, Panagiotidis P, et al.: Ultra short manic-like episodes after antidepressant augmentation with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:891\u2013892.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"82_CR41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/appi.ajp.2007.07081279","volume":"165","author":"D.T. Plante","year":"2008","unstructured":"Plante DT: Treatment-emergent hypomania or mania with modafinil. Am J Psychiatry 2008, 165:134\u2013135.","journal-title":"Am J Psychiatry"},{"key":"82_CR42","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1176\/appi.ajp.2007.06060981","volume":"164","author":"M.A. Frye","year":"2007","unstructured":"Frye MA, Grunze H, Suppes T, et al.: A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry 2007, 164:1242\u20131249.","journal-title":"Am J Psychiatry"},{"key":"82_CR43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10401230490453743","volume":"16","author":"H. Myrick","year":"2004","unstructured":"Myrick H, Malcolm R, Taylor B, LaRowe S: Modafinil: preclinical, clinical, and post-marketing surveillance\u2014a review of abuse liability issues. Ann Clin Psychiatry 2004, 16:101\u2013109.","journal-title":"Ann Clin Psychiatry"},{"key":"82_CR44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.npp.1300600","volume":"30","author":"C.A. Dackis","year":"2005","unstructured":"Dackis CA, Kampman KM, Lynch KG, et al.: A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 2005, 30:205\u2013211.","journal-title":"Neuropsychopharmacology"},{"key":"82_CR45","unstructured":"Provigil [package insert]. Frazer, PA: Cephalon; 2007."}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-008-0082-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-008-0082-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-008-0082-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:41:13Z","timestamp":1559421673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-008-0082-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s11920-008-0082-6","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}